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ABSTRACT
Stromal cells provide a crucial microenvironment for
overlying epithelium.Herewe investigated theexpression
and function of a stromal cell-speciﬁc protein, stromal
cell-derived factor-1 (SDF-1), in normal human skin and in
the tissues of diseased skin. Immunohistology and laser
capture microdissection (LCM)-coupled quantitative real-
time RT-PCR revealed that SDF-1 is constitutively and
predominantly expressed in dermal stromal cells in nor-
mal humanskin in vivo. To our surprise, an extremely high
level of SDF-1 transcriptionwas observed in the dermis of
normal human skin in vivo, evidenced by much higher
mRNA expression level than type I collagen, the most
abundant and highly expressed protein in human skin.
SDF-1was also upregulated in the tissues ofmanyhuman
skin disorders including psoriasis, basal cell carcinoma
(BCC), and squamous cell carcinoma (SCC). Double
immunostaining for SDF-1 andHSP47 (heat shock protein
47), a marker of ﬁbroblasts, revealed that ﬁbroblasts were
the major source of stroma-cell-derived SDF-1 in both
normal and diseased skin. Functionally, SDF-1 activates
the ERK (extracellular-signal-regulated kinases) pathway
and functions as a mitogen to stimulate epidermal
keratinocyte proliferation. Both overexpression of SDF-1
in dermal ﬁbroblasts and treatment with rhSDF-1 to the
skin equivalent cultures signiﬁcantly increased the num-
ber of keratinocyte layers and epidermal thickness. Con-
versely, the stimulative function of SDF-1 on keratinocyte
proliferation was nearly completely eliminated by inter-
fering with CXCR4, a speciﬁc receptor of SDF-1, or by
knock-down of SDF-1 in ﬁbroblasts. Our data reveal that
extremely high levels of SDF-1 provide a crucial
microenvironment for epidermal keratinocyte prolifera-
tion in both physiologic and pathologic skin conditions.
KEYWORDS SDF-1, dermal ﬁbroblast, keratinocyte,
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INTRODUCTION
Human skin is the largest organ of the human body, and is
composed mainly of two layers: the epidermis (outermost
layer) and the dermis (vascular connective tissue below the
epidermis). The epidermis is primarily composed of ker-
atinocytes and the dermis is composed of a dense collagen-
rich extracellular matrix (ECM) and stromal cells such as
ﬁbroblasts. The complex organization of skin is designed to
support the skin’s numerous functions, including forming a
protective barrier from environmental stresses such as water
loss and microorganism infection.
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In human skin the dermis not only provides the structural
and mechanical properties of the skin (Uitto, 1986), but also
intimately interacts with the epidermis to maintain skin
homeostasis (Maas-Szabowski et al., 1999; Tuanet al., 1994).
Interactions between mesenchymal stromal cells and epithe-
lial cells play an important role in regulating tissue develop-
ment, homeostasis, regeneration, and tumorigenesis
(Donjacour and Cunha, 1991). In human skin, stromal cells
such as dermal ﬁbroblasts provide a crucialmicroenvironment
for epidermal keratinocyte function (Blanpain and Fuchs,
2009). However, not much is known about the molecular
details and the factors responsible for such complex interac-
tions between dermal stromal cells and epidermal ker-
atinocytes in both physiologic and pathologic conditions.
In this study we aimed to examine the expression and
function of stromal cell-derived factor-1 (SDF-1 or CXCL12),
a chemokine that is secreted by stromal cells and acts on
neighboring cells. SDF-1 has been found to play an impor-
tant role in inﬂammation, proliferation, tumorigenicity, and
metastasis (Kryczek et al., 2007; Luker and Luker, 2006;
Orimo et al., 2005). For example, SDF-1 promotes tumor
growth through stimulation of angiogenesis and by secretion
of several mitogens (Chen et al., 2006; Chu et al., 2009;
Wang et al., 2005). However, the role and expression of
SDF-1 in normal human skin and skin disorders have not
been comprehensively documented. Here we demonstrate
that SDF-1 is constitutively and predominantly expressed in
normal human skin dermis with extremely high expression
levels. Moreover, SDF-1 is greatly upregulated in patholog-
ical conditions of human skin including psoriasis and ker-
atinocyte skin cancers, BCC and SCC. Functional studies
indicate that SDF-1 is mainly secreted by dermal ﬁbroblasts
and functions as a mitogen for epidermal keratinocyte pro-
liferation through activation of the ERK/MAPK pathway, the
predominant growth pathway in skin keratinocytes (Cham-
bard et al., 2007; Eckert et al., 2002; Jost et al., 2001).
RESULTS
SDF-1 is substantially expressed in normal human skin
Although SDF-1 expression in human skin has been reported
(Pablos et al., 1999), its expression levels, patterns, and cell
type-speciﬁc expression in normal human skin compartments
remain incompletely understood. Immunostaining for SDF-1
on sections of normal human skin revealed that SDF-1
expressionwas largely restricted to stromal cells in the dermal
compartment (Fig. 1A), such as dermal ﬁbroblasts (Fig. 1A,
middle insert) and vascular endothelial cells (Fig. 1A, lower
insert). Interestingly we noticed that SDF-1 staining wasmuch
higher in papillary dermal cells, which reside in the superﬁcial
dermis, than in reticular dermal cells.No stainingwasdetected
with isotype matched control IgG (Fig. 1A, right). Double
immunostaining for SDF-1 and HSP47, a marker of ﬁbrob-
lasts, revealed co-localization indicating that the majority
of SDF-1 positive cells were dermal ﬁbroblasts (Fig. 1B).
In addition to dermal stromal cells, scattered epidermal cells
were also stained with SDF-1 (Fig. 1A, top insert). Double
immunostaining for SDF-1 and langerin, a marker of langer-
hans cells, revealed co-localization indicating that the scat-
tered SDF-1 positive cells in the epidermis were langerhans
cells (Fig. 1C). Next we determined the relative mRNA
expression levels of SDF-1 in the epidermis and dermis by
laser capturemicrodissection-coupled real-time RT-PCR (Qin
et al., 2013) (Fig. 1D). Surprisinglywe found thatSDF-1mRNA
levelswereextremely high in thedermisof normal humanskin,
evidenced by much higher mRNA level than the housekeep-
ing gene mRNA, 36B4 (Fig. 1D). Further investigation indi-
cated that the SDF-1 mRNA level was much higher than
mRNA level of type I collagen (Fig. 1E), the most abundant
protein in human skin, and matrix metallopriteianse-1 (MMP-
1), which has been shown to have a very low expression level
in normal skin (Quan et al., 2009). Next we investigated the
localization of CXCR4, the speciﬁc receptor for SDF-1, in
human skin. As shown in Fig. 1F, CXCR4 was predominantly
expressed in human skin epidermis. Taken together, these
data demonstrate that SDF-1 is constitutively and extremely
highly expressed in normal human skin dermis, suggesting
SDF-1 may play an important role in skin homeostasis in
physiological conditions.
SDF-1 is overexpressed in human keratinocyte skin
cancers
Wenext examined SDF-1 expression in human skin BCC and
SCC, two major keratinocyte skin cancers. SDF-1 immunos-
taining of BCC skin sections revealed a much greater cellular
staining in BCC-associated stroma (Fig. 2A). Interestingly,
BCC keratinocytes were also positively stained with SDF-1,
while in normal human skin keratinocytes were completely
negative (Fig. 1A). Double immunostaining for SDF-1 and
HSP47 revealed co-localization, indicating the majority of
SDF-1 positive cells were ﬁbroblasts in theBCCstroma. LCM-
coupled quantitative real-time RT-PCR indicated that the
SDF-1 mRNA levels were signiﬁcantly elevated in BCC and
BCC-associated stroma compared to normal epidermis and
dermis, respectively (Fig. 2B). SDF-1 immunostaining of SCC
skin sections resulted in similar patterns, showing signiﬁcantly
elevated SDF-1 levels in SCC-associated stroma and SCC
(Fig. 3A). Double immunostaining for SDF-1 and HSP 47
conﬁrmed the co-localization, indicating that ﬁbroblasts were
expressing SDF-1 in the SCC stroma. Additionally, the
majority of SDF-1 positive cells in SCC-stroma were co-lo-
calized with α-smooth muscle actin (α-SMA), a marker for
myoﬁbroblasts (Fig. 3B). LCM-derived SCC and stromal tis-
sue indicated that SDF-1 mRNA levels were signiﬁcantly
elevated in both SCC and SCC-associated stromal tissues
compared to normal epidermis and dermis, respectively
(Fig. 3C). These data demonstrate that SDF-1 is signiﬁcantly
upregulated in both BCC/SCC-associated stromal ﬁbroblasts
and BCC/SCC keratinocytes.
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SDF-1 expression is up-regulated in human psoriatic
skin
Next we investigated SDF-1 expression in skin of patients
with psoriasis, a common chronic inﬂammatory skin disorder.
Immunostaining of sections of human psoriatic tissue
indicated increased SDF-1 staining which was largely
restricted to the dermal cells and scattered epidermal cells,
presumably langerhans cells (Fig. 4A). Interestingly, SDF-1
was most highly expressed at the dermal-epidermal junction
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Figure 1. SDF-1 is predominantly expressed in normal human skin dermis with extremely high levels. (A) SDF-1 protein
expression and localization in normal human skin. OCT-embedded skin sections (7 μm) were immunostained with SDF-1 antibody
(left) and isotype control antibody (mouse IgG1, right). Bar = 100 µm. 2.5× enlargement of the boxed region is shown to the right (top,
epidermis; middle, ﬁbroblasts; lower, vascular endothelial cells, bar = 50 µm). Representative of six individuals. (B) The majority of
SDF-1 positive cells were dermal ﬁbroblasts. OCT-embedded skin sections (7 μm) were co-immunoﬂuoresce stained with SDF-1 and
HSP47, a marker of dermal ﬁbroblast. Arrows indicate double stained cells. Representative of ﬁve individuals. Bar = 50 µm.
(C) Langerhans cells were stained with SDF-1 in epidermis. OCT-embedded skin sections (7 μm) were co-immunoﬂuoresce stained
with SDF-1 and Langerin, a marker of langerhans cell. Arrow heads indicate double stained cells. Lines indicate epidermal and
dermal junctions. Representative of six individuals. Bar = 50 µm. (D) An extremely high level of SDF-1 mRNA expression in dermis
was conﬁrmed by Laser capture microdisection (LCM) coupled quantitative real-time RT-PCR. Epidermis and dermis were captured
by LCM. Total RNA was extracted from captured tissue, and mRNA levels were quantiﬁed by real-time RT-PCR. SDF-1 mRNA levels
were normalized to the housekeeping gene 36B4 as an internal control for quantiﬁcation. Data are relative levels to 36B4
(mean ± SEM), n = 6, *P = 0.001. (E) SDF-1 mRNA expression is higher than type I collagen mRNA expression. Total RNA was
extracted from LCM-captured dermis and mRNA levels were quantiﬁed by real-time RT-PCR. The target gene expression levels were
presented relative to an internal control (36B4). Data are relative levels to 36B4 (mean ± SEM), n = 6–10. (F) CXCR4 protein
expression and localization in normal human skin. OCT-embedded skin sections (7 μm) were immunostained with CXCR4 antibody
(left) and isotype control antibody (mouse IgG1, right). Lines indicate epidermal and dermal junction. Representative of six individuals.
Bar = 100 µm.
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tissue (Fig. 4A, right). Quantiﬁcation indicated that the SDF-1
mRNA level was increased 8.2-fold in psoriatic tissue com-
pared to non-lesional normal skin in the same patients.
SDF-1 activates ERK pathway and enhances
keratinocyte proliferation
Prior human skin in vivo studies indicated that SDF-1 is
predominantly expressed in the dermis of normal human
skin and signiﬁcantly elevated in the pathological conditions
of several skin disorders. These data prompted us to
investigate the role of SDF-1 in human skin. To this end, we
ﬁrst investigated the expression of SDF-1 and its receptor
CXCR4 in two major cell types in human skin, dermal
ﬁbroblasts and epidermal keratinocytes. In agreement with
our human skin in vivo results (Fig. 1A), we conﬁrmed that
SDF-1 mRNA was speciﬁcally expressed in primary human
dermal ﬁbroblasts but not in primary human keratinocytes
(Fig. 5A). In contrast to SDF-1, keratinocytes, but not the
ﬁbroblasts, expressed the receptor CXCR4. Western
analysis further conﬁrmed that SDF-1 and its receptor
CXCR4 are speciﬁcally expressed in ﬁbroblasts and ker-
atinocytes, respectively (Fig. 5B). Since SDF-1/CXCR4
interaction has been shown to activate several signaling
pathways including MAPK in various cell lines (Chu et al.,
2009; Kijima et al., 2002), we performed Western blot anal-
ysis to elucidate ERK activation, a predominant growth
pathway in skin keratinocytes (Chambard et al., 2007; Eckert
et al., 2002; Jost et al., 2001). SDF-1 rapidly activated the
ERK1/2 pathway in primary keratinocytes as evidenced by
elevated phosphorylation of p42 and p44 (p-ERK1/2)
(Fig. 5C), which was greatly reduced by ADM3100, a highly
speciﬁc CXCR4-antagonist, and U0126, a speciﬁc MEK
inhibitor. In agreement with ERK activation, addition of
recombinant human SDF-1 to the keratinocyte culture
medium resulted in increased keratinocyte proliferation
(Fig. 5D) and cell number quantiﬁcation (Fig. 5E). The role of
SDF-1 as a mitogen for primary keratinocytes was further
demonstrated by interfering with a speciﬁc CXCR4-antago-
nist, ADM3100 (Fig. 5D and 5E). Next we investigated the
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Figure 2. SDF-1 is overexpressed in human skin basal cell carcinoma (BCC). (A) SDF-1 immunostaining in human BCC. OCT-
embedded BCC sections (7 μm) were co-immunoﬂuoresce stained with SDF-1 and HSP47. Circles indicate BCC islands.
Representative of six BCC tissues. Bar = 100 µm. 2.5× enlargement of the boxed region is shown to the bottom (bar = 50 µm).
Representative of six individuals. (B) SDF-1 mRNA expression in BCC and BCC-associated stromal tissue. BCC, BCC-associated
stromal tissue, normal epidermis and dermis were captured by LCM. Total RNA was extracted from captured tissues, and mRNA
levels were quantiﬁed by real-time RT-PCR. SDF-1 mRNA levels were normalized to the housekeeping gene 36B4 as an internal
control for quantiﬁcation. Data are relative levels to 36B4 (mean ± SEM), n = 12, *P = 0.007, **P = 0.02.
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role of SDF-1 in keratinocyte proliferation using gain- and
loss-of-function approaches. Figure 5F shows the knock-
down efﬁciency of SDF-1 (see Figs. S1 and S2 for detailed
information of off-target effects). Among three SDF-1 siRNAs
tested, #1 SDF-1 siRNA showed the highest knockdown
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Figure 3. SDF-1 is overexpressed in human skin squamous cell carcinoma (SCC). (A) SDF-1 immunostaining in human SCC.
OCT-embedded SCC sections (7 μm) were co-immunoﬂuoresce stained with SDF-1 and HSP47. Bar = 100 µm. Outlines indicate
SCC islands. 3.5× enlargement of the boxed region is shown to the bottom (bar = 50 µm). Representative of six SCC tissues.
(B) Double immunostaining for SDF-1 and α-smooth muscle actin (α-SMA). Outlines indicate SCC islands. Representative of six SCC
tissues. Bar = 100 µm. 2× enlargement of the boxed region is shown to the bottom (bar = 50 µm). Representative of six individuals.
(C) SDF-1 mRNA expression in SCC and SCC-associated stromal tissue. SCC, SCC-associated stromal tissue, normal epidermis
and dermis were captured by LCM. Total RNA was extracted from captured tissues, and mRNA levels were quantiﬁed by real-time
RT-PCR. SDF-1 mRNA levels were normalized to the housekeeping gene 36B4 as an internal control for quantiﬁcation. Data are
relative levels to 36B4 (mean ± SEM), n = 12, *P = 0.03, **P = 0.04.
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experiments. To test epidermal keratinocyte proliferation, we
employed a skin equivalent culture system, which is a well-
characterized model to study the interaction of epidermal
keratinocytes and dermal ﬁbroblasts (Boelsma et al., 1999;
Pickard et al., 2012; Ridky et al., 2010). Skin equivalent
cultures are composed of stratiﬁed, differentiated ker-
atinocytes (model epidermis) on top of a type I collagen
lattice in which dermal ﬁbroblasts are embedded (model
dermis). Both overexpression of SDF-1 in dermal ﬁbroblasts
and treatment with rhSDF-1 to the skin equivalent cultures
signiﬁcantly increased the number of keratinocyte layers
(Fig. 5G). In contrast, knock-down SDF-1 levels in dermal
ﬁbroblasts resulted in a signiﬁcant inhibition of the number of
keratinocyte layers. Quantiﬁcation indicated that the thick-
ness of the keratinocyte layers was increased by more than
150% (Fig. 5H) with either overexpression of SDF-1 in der-
mal ﬁbroblasts or treatment with rhSDF-1. In contrast, knock-
down SDF-1 levels in dermal ﬁbroblasts reduced the thick-
ness of the keratinocyte layers by 33%. To further assess the
proliferation of epidermal keratinocytes, we performed a
thymidine incorporation assay by directly measuring DNA
synthesis in mitotic keratinocytes. In agreement with
epidermal thickness (Fig. 5G and 5H), DNA synthesis was
signiﬁcantly increased by either rhSDF-1 or overexpression
of SDF-1 in dermal ﬁbroblasts, compared to control. In
contrast, knock-down SDF-1 levels in dermal ﬁbroblasts
reduced DNA synthesis. Taken together, these data
demonstrate that SDF-1 is secreted from dermal ﬁbroblasts
and functions as a mitogen for epidermal keratinocytes.
DISCUSSION
Surprisingly, we found that basal expression of SDF-1
mRNA levels were extremely high in normal human skin
dermis in vivo. SDF-1 mRNA levels were several folds higher
than type I collagen mRNA, the most abundant ECM protein
in human skin. Given that the SDF-1 mRNA level is even
greater than collagen, SDF-1 may play an important role in
skin homeostasis under physiological conditions. This notion
is supported by our data that ﬁbroblast-derived SDF-1
functions as a mitogen to stimulate keratinocyte proliferation
and thus may contribute to epidermal turnover and mor-
phogenesis. In normal skin the epidermis constantly turns


























Figure 4. SDF-1 is overexpressed in human psoriatic skin. (A) SDF-1 immunostaining in human psoriatic skin. OCT-embedded
psoriatic sections (7 μm) were stained with SDF-1. Bar = 100 µm. 7.5× (left) and 4.5× (right) enlargement of the boxed regions are
shown to the bottom (bar = 50 µm). Representative of six individuals. (B) SDF-1 mRNA expression in psoriatic skin. Total RNA was
extracted from psoriatic tissue or non-lesional normal skin in the same patients. SDF-1 mRNA levels were quantiﬁed by real-time RT-
PCR and normalized to the housekeeping gene 36B4 as an internal control for quantiﬁcation. Data are relative levels to 36B4
(mean ± SEM), n = 6, *P = 0.02.
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in mice (Potten, 1981). This constantly high level of epider-
mal turnover is mediated by epidermal stem cells (Koster,
2009), which reside in the basal layer of the epidermis. Stem
cells in the epidermis have a crucial role in maintaining tis-
sue homeostasis by providing new cells to replace those that
are constantly lost during tissue turnover. Given that SDF-1
functions as a mitogen to stimulate epidermal keratinocyte
proliferation, it is conceivable that SDF-1 might be involved
in epidermal stem cell survival and proliferation that con-
tribute to epidermal turnover. In agreement with this notion,
SDF-1 has been shown to play an important role in
hematopoietic and progenitor stem cell motility and devel-
opment in both human and murine (Koster, 2009; Wright
et al., 2002). SDF-1 is highly expressed in the bone marrow
by various stromal cells including osteoblasts, endothelial
cells, and perivascular reticular cells (Lapidot et al., 2005;
Sugiyama et al., 2006). Notably, SDF-1 is also involved in
other stem cell functions including regulation of cell quies-
cence and survival (Nie et al., 2008; Sugiyama et al., 2006).
Our data suggest that extremely high levels of SDF-1 in the
dermis might be required for skin homeostasis, including
epidermal turnover and morphogenesis. Notably normal
human skin does not display overt inﬂammation, suggesting
that SDF-1 may function as an important mitogen in physi-
ological conditions rather than as a chemokine, a well-known
major function of SDF-1 which activates leukocytes and is
often induced by proinﬂammatory stimuli. Nevertheless,
future studies must be carried out to determine how SDF-1
does play a role in skin homeostasis, epidermal turnover,
and morphogenesis under physiological conditions.
Interestingly, Takekoshi et al. recently reported that SDF-
1/CXCR4 signaling normally limits keratinocyte proliferation
instead of stimulation in keratinocyte-speciﬁc CXCR4
knockout mouse models (Nishimura et al., 2012). Some
existing literatures support this concept, whereas others
contradict it (Bollag and Hill, 2013). Obviously, the precise
roles of the SDF-1/CXCR4 axis in human skin appear to be
complex. It is worth mentioning that a second SDF-1
receptor, CXCR7, has been recently identiﬁed (Duda et al.,
2011). Indeed, some of the functions of SDF-1 are mediated
through CXCR7 rather than CXCR4. CXCR7 has also been
implicated in regulating cell proliferation, adhesion, and
migration (reviewed in Maksym et al., 2009). Additionally,
AMD3100, a known CXCR4 inhibitor, appears to act as an
agonist at the CXCR7 receptor (Kalatskaya et al., 2009),
suggesting that additional investigation of this important
SDF-1/CXCR4/CXCE7 axis in skin biology is clearly
warranted.
The critical role of dermal ﬁbroblasts in regulating epi-
dermal morphogenesis has been reported (El Ghalbzouri
et al., 2002). For example, in the absence of ﬁbroblasts the
epidermis formed very thin cell and stratum corneum layers.
However, in the presence of ﬁbroblasts the proliferation and
migration of keratinocytes was stimulated and epidermal
morphology was markedly improved. These data suggest
that ﬁbroblasts are required for epidermal morphogenesis by
providing growth factors needed for the generation of a fully
differentiated epidermis. This notion is supported by our
recent evidence demonstrating that improvement of aged
dermal ﬁbroblast function in vivo signiﬁcantly increased
epidermal keratinocyte proliferation and thus increased epi-
dermal thickness, which is a prominent feature of aged
human skin (Quan et al., 2013). Comparing SDF-1 expres-
sion in papillary and reticular dermal ﬁbroblasts, we noticed
that papillary dermal ﬁbroblasts expressed much higher
SDF-1 levels than reticular dermal ﬁbroblasts, suggesting
papillary dermal ﬁbroblasts are the major source of SDF-1
and are actively involved in epidermal morphogenesis. In
agreement with this notion, Mine et al. reported that dermal
equivalents containing papillary dermal ﬁbroblasts were
more potent in promoting epidermal morphogenesis than
those containing reticular dermal ﬁbroblasts (Mine et al.,
2008).
Although SDF-1 expression is extremely high in normal
human skin, its expression is even greater in human skin
keratinocyte hyperproliferative disorders. We found that
SDF-1 positive stromal cells are restricted to the dermal-
epidermal junction in both psoriatic lesional tissue and
adjacent tissue, suggesting stromal cell-derived SDF-1 may
play an important role in the development of chronic skin
inﬂammation. The hallmark of psoriasis is hyperproliferation
of keratinocytes leading to thickening of the epidermis and
elongated rete ridges that form ﬁngerlike protrusions into the
dermis. Given the stimulative function of SDF-1 on epidermal
keratinocyte proliferation, it is imaginable that elevated
stromal cell-derived SDF-1 might be actively involved in the
hallmark of psoriasis, hyperproliferation of keratinocytes and
thickening of the epidermis. This concept has been investi-
gated in experimental models of chronic psoriasis-like skin
inﬂammation, which reveal an important role of the SDF-1/
CXCR4 axis in skin inﬂammation (Zgraggen et al., 2014).
Elevated expression of SDF-1 has been reported in a
number of cancer-associated stroma (Kryczek et al., 2007),
including keratinocyte skin cancers (Chen et al., 2009). This
study demonstrates the expression of SDF-1 in tumor stro-
mal ﬁbroblasts and appendages, but not in BCC epithelial
cancer cells. In contradiction, we found that in keratinocyte
skin cancers epithelial cancer cells are positively stained
with SDF-1, while in normal human skin keratinocytes are
completely negative. It is possible that the high level of
immunostaining of SDF-1 in cancer cells resulted from
accumulation of secreted SDF-1 by stromal cells through
SDF-1/CXCR4 interaction. However, LCM-captured BCC/
SCC islands further conﬁrmed the high expression of SDF-1
transcription in epithelial cancer cells compared to normal
skin epidermis. The reasons for this discrepancy are not
clear at this time. Although the nature of SDF-1 positive
epithelial cells in keratinocyte skin cancers is not known, one
possibility is that SDF-1 may promote epithelial-mesenchy-
mal transition (EMT) and thus they express stromal marker
SDF-1. In agreement with this notion, we observed HSP47, a
marker of stromal ﬁbroblasts, positive cells surrounding BCC
RESEARCH ARTICLE Chunji Quan et al.









(Fig. 2) and SCC (Fig. 3) islands, indications of EMT. EMT
refers to critical events in tumor progression including inva-
sion and metastasis by which cancer cells acquire a ﬁbrob-
last-like phenotype. Indeed, it has been reported that SDF-1/
CXCR4 promotes EMT and progression of colorectal cancer
(Hu et al., 2014), oral squamous cell carcinoma, (Onoue
et al., 2006), hepatocellular carcinoma (Li et al., 2014), and
pancreatic cancer cells (Li et al., 2012). Nevertheless, can-
cer-associated stromal cells are heavily stained with SDF-1
suggesting an important role of stromal cell-derived SDF-1 in
skin cancer progression including the possibility of promoting
cancer cell EMT.
It is becoming increasingly clear that stromal microenvi-
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progression (Mueller and Fusenig, 2004; Quail and Joyce,
2013). Particularly, research shows that activated ﬁbroblasts,
often referred to as carcinoma-associated-ﬁbroblasts
(CAFs), play an important role in promoting tumorigenesis
(Bhowmick et al., 2004; Straussman et al., 2012). Orimo
et al. reports that CAFs from human breast carcinomas aid
the growth of tumor cells by secreting SDF-1. Their study
shows that CAFs produce SDF-1 which in turn mediates
tumor angiogenesis by recruiting endothelial progenitor cells
(Orimo et al., 2005). In agreement with this, we found sig-
niﬁcantly increased angiogenesis in both BCC and SCC
(Fig. S1), suggesting that stromal cell derived SDF-1 not only
functions as a mitogen to stimulate epithelial cancer cell
growth, but also to promote tumor angiogenesis.
We found that the majority of SDF-1 positive cells are
dermal ﬁbroblasts in both normal and diseased skin. Dermal
ﬁbroblasts are the most populated stromal cells in human
skin. It is well-known that the major function of dermal
ﬁbroblasts is to synthesize collagen-rich ECM (Farage et al.,
2010; Fisher et al., 2008). Dermal ﬁbroblasts secrete the
precursors of all the components of the ECM proteins in skin.
Therefore, the main function of dermal ﬁbroblasts is to
maintain the structural and mechanical integrity of dermal
connective tissue by continuously synthesizing and secret-
ing collagen and other ECM proteins. Our ﬁndings suggest
that besides its important role in ECM production, dermal
ﬁbroblasts are also an important source of mitogens and
thus are actively involved in skin homeostasis by regulating
epidermal keratinocyte proliferation and turnover.
The regulation of epidermal keratinocyte function by
paracrine effectors from the dermal microenvironment has
been well established in human skin in vivo. However, a
more complete understanding of these relationships has
been delayed due, in part, to a lack of appropriate in vitro
culture models. In this study we describe a skin equivalent
culture model which demonstrates that normal paracrine
relationships can be reconstituted in vitro and that stromal
dermal ﬁbroblasts regulate the growth of human epithelial
keratinocytes. Interesting differences in the proliferation of
epithelial keratinocytes were noted in the presence or
absence of SDF-1. Therefore, skin equivalent culture is a
promising model to investigate the interactions between
stromal cells and epithelial cells and understand the
molecular basis of paracrine effectors from the dermal
microenvironment.
To investigate the potential role of the SDF-1/CXCR4
axis, we performed in vitro studies using AMD3100, a
speciﬁc CXCR4-antagonist (Byrne and Sarchio, 2014;
Pablos et al., 1999). Our studies conﬁrmed that AMD3100
efﬁciently blocks SDF-1 interaction with CXCR4 and thus
inhibits the activation of ERK and stimulation of keratinocyte
proliferation (Fig. 5). AMD3100 has been used clinically as
an immunostimulant that mobilizes hematopoietic stem cells
in cancer patients (Plerixafor, trade name Mozobil). Our
results provide a new therapeutic implication to treat hyper-
proliferative inﬂammatory skin diseases using AMD3100. In
agreement, AMD3100 has been shown to have beneﬁcial
effects in animal models of skin inﬂammation (Zgraggen
et al., 2014) and UV-induced skin cancer (Sarchio et al.,
2014). AMD3100 signiﬁcantly inhibited skin inﬂammation by
reducing inﬂammatory angiogenesis and inﬂammatory cell
accumulation, and thus preventing skin inﬂammation and
UV-induced skin cancer development. Hence, the SDF-1/
Figure 5. SDF-1 activates ERK pathway and functions as a
mitogen to promote keratinocyte proliferation. (A) SDF-1
mRNA and its receptor CXCR4 were speciﬁcally expressed in
ﬁbroblasts and keratinocytes, respectively. Total RNA was
extracted from primary dermal ﬁbroblasts and keratinocytes.
SDF-1 and CXCR4 mRNA levels were quantiﬁed by real-time
RT-PCR and normalized to the housekeeping gene 36B4 as an
internal control for quantiﬁcation. Data are relative levels to
36B4 (mean ± SEM), n = 4. (B) SDF-1 protein and its receptor
CXCR4 were speciﬁcally expressed in ﬁbroblasts and ker-
atinocytes, respectively. Whole cell extract was prepared from
primary dermal ﬁbroblasts and keratinocytes. Protein levels
were determined by Western analysis. n = 2. (C) SDF-1 rapidly
activated the ERK1/2 in primary keratinocytes, and that was
reduced by CXCR4 (ADM3100) and MEK (U0126) inhibitors.
Cells were pretreated with CXCR4 or MEK inhibitors or
remained untreated (control). These cells were then treated
with rh SDF-1 (150 ng/mL) at indicated times. Whole cell extract
was prepared and protein levels were determined by Western
analysis. n = 3. (D) SDF-1 promotes keratinocytes proliferation.
Cells were pretreated with CXCR4 antagonist (ADM3100) or
PBS (control). These cells were then treated with rh SDF-1
(150 ng/mL). Five days after treatment, cells were pho-
tographed (phase-contract microscopy), harvested, and
counted using a hemocytometer. Bar = 100 µm. (E) Results
are means ± SEM, n = 3. *P = 0.04, **P = 0.03. Bar = 100 µm.
(F) Efﬁciency of knockdown by SDF-1 siRNAs. SDF-1 protein
levels were determined 2 days after transfection with SDF-1
siRNAs by Western blot analysis. Band intensities were
quantiﬁed by chemiﬂuorescence and normalized to internal
control β-actin. The insert shows a representative Western blot.
Data are means ± SEM. n = 3. *P = 0.05, (G) Skin equivalent
cultures were prepared as described in “Materials and meth-
ods”. Dermal ﬁbroblasts were infected with control adenovirus
(second left) or premade adenovirus SDF-1 (second right)
before being embedded in collagen lattices. Skin equivalent
culture was treated with rh SDF-1 (200 ng/mL) for seven days
(middle). Air-lifted skin equivalent cultures were harvested and
embedded in OCT, and cryo-sections were stained with H&E.
Bar = 100 µm. 4.6× enlargement of the boxed regions are
shown to the bottom (bar = 25 µm). Representative of three
experiments. (H) The epidermal thickness was measured by
computerized image analysis. Results are means ± SEM, n = 4.
*P = 0.03 vs. CTRL, **P = 0.01 vs. CTRL vector, ***P = 0.01 vs.
si CTRL. (I) Proliferation of epidermal keratinocytes was
determined by [3H]thymidine incorporation assay, as described
in “Materials and methods”. Results are means ± SEM, n = 3.
*P = 0.03 vs. CTRL, **P = 0.02 vs. CTRL vector, ***P = 0.05 vs.
si CTRL.
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CXCR4 chemokine pathway is a novel therapeutic target in
the prevention of skin inﬂammation and UV-induced skin
cancer. The role of the SDF-1/CXCR4 axis in skin wound
healing is more complex and contradictory (Bollag and Hill,
2013). A single topical application of AMD3100 resulted in
accelerated wound healing in diabetic mouse models
through enhancement of angiogenesis and vasculogenesis
(Nishimura et al., 2012). The studies from Lin et al. further
conﬁrmed and extended these ﬁndings by identifying that
AMD3100 can recruit stem cells into the wound sites and
thus accelerates wound healing (Lin et al., 2014). In contrast,
other studies have shown that topical application of SDF-1
itself to wound sites enhances healing (Gallagher et al.,
2007; Henderson et al., 2011; Rabbany et al., 2010; Sarkar
et al., 2011). Nevertheless, the SDF-1/CXCR4 pathway has
been implicated in skin wound healing, however, additional
investigation of this important SDF-1/CXCR4 axis in skin
wound healing is clearly warranted.
We propose a working model in which ﬁbroblast-derived
SDF-1 provides a crucial microenvironment for epidermal
morphogenesis in both physiological and pathological skin
conditions (Fig. 6). In physiologically normal human skin,
SDF-1 is constitutively and highly expressed in the dermal
ﬁbroblasts. Fibroblast-derived SDF-1 promotes keratinocyte
proliferation and thus contributes to epidermal turnover and
morphogenesis through paracrine signaling. In pathological
conditions, SDF-1 expression is further upregulated in der-
mal ﬁbroblasts and thus contributes to keratinocyte hyper-
proliferative skin disorders, such as psoriasis and
keratinocyte skin cancers. Our data reveal that SDF-1 rep-
resents a novel dermal ﬁbroblast-speciﬁc factor in the
paracrine network, and extremely high levels of SDF-1 pro-
vide a crucial microenvironment for epidermal keratinocyte




Adult normal human skin samples were obtained by punch biopsy
(4 mm) from sun-protected (hip/buttocks) areas of healthy adults
(30–40 years), as described previously (Quan et al., 2010). Psoriatic
skin samples were obtained by punch biopsy (4 mm) from psoriasis
patients. Completely de-identiﬁed BCC and SCC samples were
obtained from the University of Michigan Cutaneous Oncology Unit.
Research involving human subjects was approved by the University
of Michigan Institutional Review Board, and informed consent (both
written and verbal) was obtained from patients for the use of their
skin samples in this research project.
Laser capture microdissection
For laser capture microdissection (LCM), skin samples embedded in
OCT were sectioned (15 µm) and stained with hematoxylin and
eosin. Epidermis, dermis, tumor islands, and cancer-associated
stromal tissues were captured by LCM (Leica ASLMD system; Leica
Microsystems, Wetzlar, Germany), as described previously (Qin
et al., 2013). Total cellular RNA was extracted from samples of laser-
dissected tissues using an RNeasy® Micro Kit (Qiagen, Chatsworth,
CA, USA) according to the manufacturer’s instructions. The quality
and quantity of total RNA were determined by Agilent 2100 bioan-
alyzer (Agilent Technologies, Santa Clara, CA, USA).
Immunohistology
Immunohistology was performed as described previously (Quan
et al., 2010). Brieﬂy, skin samples embedded in OCTwere sectioned
(7 µm), ﬁxed in 2% paraformaldehyde, permeabilized with 0.5%
Triton X-100 in phosphate-buffered saline (PBS), blocked with cor-
responding serum (5% in PBS), and incubated for one hour at room
temperature with SDF-1 (R&D Research, Minneapolis, MN, USA),
HSP47, langerin, CD31, CXCR4, and α-smooth muscle actin pri-
mary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA), fol-
lowed by incubation with corresponding secondary antibodies for
one hour at room temperature. Between steps, the slides were
rinsed for 10 min in Tris buffered saline with 0.1% Triton-X-100
(TBST). All sections were lightly counterstained with haematoxylin.
The slides were examined using a digital imaging microscope
(Zeiss, Germany). Speciﬁcity of staining was determined by substi-
tuting corresponding isotype-control immunoglobulins for the pri-
mary antibodies.
Cell culture
Human primary keratinocytes were obtained from Cascade Biolog-
ics Inc. (Portland, OR). Adult human primary dermal ﬁbroblasts were
prepared from punch biopsies of normal adult buttock skin (aged
22–55 years), as described previously (Fisher et al., 1991). Ker-
atinocytes were maintained in Epilife medium supplemented with
keratinocyte growth supplement. Dermal ﬁbroblasts were main-
tained in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum (Invitrogen, Carlsbad, CA).
Epilife and DMEM media were supplemented with penicillin
CXCR4




Figure 6. Proposed model: ﬁbroblast-derived SDF-1 pro-
vides a crucial microenvironment for epidermal morpho-
genesis in both physiological and pathological skin
conditions (see “Discussion” for details).
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(100 U/mL) and streptomycin (100 μg/mL). Cells were cultured in a
humidiﬁed incubator with 5% CO2 at 37°C. Cells were plated at 70%–
80% conﬂuence and used one day after plating. Cells were cultured
at sub-conﬂuence and utilized between passages 5 and 10. Six days
after transfection, cultures were photographed (phase-contract
microscopy) and cell numbers determined by hemocytometer.
RNA isolation and quantitative real-time RT-PCR
Total RNA was extracted using TRizol reagent (Invitrogen, Carlsbad,
CA), or RNeasy micro kit (Qiagen, Gaithersburg, MD, USA). cDNA
for PCR templates was prepared by reverse transcription of total
RNA (100 ng) using Taqman Reverse Transcription kit (Applied
Biosystems, Carlsbad, CA, USA). Real-time PCR was performed on
a 7700 Sequence Detector (Applied Biosystems, Carlsbad, CA,
USA) using Taqman Universal PCR Master Mix Reagents (Applied
Biosystems, Carlsbad, CA, USA). SDF-1 real-time PCR primers
were designed and purchased from Sigma: sense primer 5′-AGC-
CAA-CGT-CAA-GCA-TCT-CAA-3′; antisense primer 5′-AAT-CCA-
CTT-TAG-CTT-CGG-GTC-AA-3′. 36B4 primer sequences have
been described previously (Quan et al., 2001). The target gene
expression levels were determined by relative quantiﬁcation using
the comparative CT method, also known as 2
-ΔΔCT method (com-
parative 2–[delta][delta]Ct method). Target gene mRNA expression
levels were normalized to the housekeeping gene 36B4 (internal
control for quantiﬁcation), and expressed as a fold change of 36B4.
Transfection and Western blot analysis
SDF-1siRNAs (#1, 5′-ACGCCAAGGTCGTGGTCGT-3′ position at
94-112, #2, 5′-TGCCGATTCTTCGAAAGCC-3′ position at 183–201,
#3, 5′-CTCCAAACTGTGCCCTTCA-3′ position at 244–262) were
designed and purchased from Sigma (St. Louis, MO, USA). SDF-1
siRNAs were transiently transfected into human skin dermal ﬁbrob-
lasts by electroporation (Amaxa Nucleofector™, Koeln, Germany).
Proteins were prepared from keratinocytes and equal amounts of
protein (∼50 μg/lane) were analyzed by resolving on 12% sodium
dodecyl sulfate-polyacrylamide (SDS) gel electrophoresis. The SDS
gels were transferred to polyvinylidenediﬂuoride membrane, and the
membranes were blocked with PBST (0.1% Tween 20 in PBS) con-
taining 5% nonfat milk for one hour at room temperature. Primary
antibodies SDF-1 (R&D Research, Minneapolis, MN, USA); α-SMA
(SantaCruzBiotechnology,SantaCruz,CA,USA);β-actin (Sigma,St.
Louis, MO, USA) were incubated with the polyvinylidenediﬂuoride
membrane for one hour at room temperature, after which membranes
were washed three times with PBST solution and incubated with
appropriate secondary antibodies for one hour at room temperature.
After washing three timeswith PBST, themembraneswere developed
with ECF (Vistra ECF Western blotting system, GE Health Care,
Piscataway, NJ, USA) following the manufacturer’s protocol. The
membranes were scanned with a STORM MolecularImager (Molec-
ular Dynamics, Sunnyvale, CA), and the ﬂuorescence intensities of
each band were quantiﬁed by ImageQuant (GE Health Care, Piscat-
away, NJ, USA) and normalized using β-actin as a marker for equal
protein loading.
Reconstruction of human skin equivalent culture
Primary adult human dermal ﬁbroblasts between passages 3–8 were
used for all experiments. Skin equivalent was prepared based on the
well-established standard protocol with minor modiﬁcation (Boelsma
et al., 1999). Brieﬂy, dermal equivalent (ﬁbroblasts-populated collagen
lattices) was prepared, as previously described (Fisher et al., 2009).
Neutralized rat tail type I collagen (2 mg/mL, BD, Biosciences, Palo
Alto, CA, USA) was suspended in medium cocktail [DMEM, NaHCO3
(44 mmol/L), L-glutamine (4 mmol/L), Folic Acid (9 mmol/L), and
neutralizedwith 1 NNaOH to pH 7.2]. 1 × 105 cells were suspended in
1mLcollagenandmediumcocktail solutionandplatedon ﬁlter inserts.
These collagen lattices were placed in an incubator at 37°C for 30min
to allow collagen polymerization. The collagen lattices were then
incubated with 2 mLmedia (DMEM, 10%FBS) at 37°C, 5%CO2. One
dayafter dermalequivalent culture, 1×105 keratinocyteswereseeded
on the dermal equivalent collagen lattices. This skin equivalent cul-
tures were grown under submerged conditions in which they were
lifted to the air-liquid interface. Cultures were maintained for seven
days immersed in amediumcomposedofMEM (Invitrogen, Carlsbad,
CA) supplemented with 10% FBS (Sigma, St Louis, MO), Hydrocor-
tisone (0.4 mg/mL) (Sigma, St Louis, MO), and Cholera Toxin
(0.1 nmol/L) (Biomol Int., Plymouth, PA) 50 µg per mL ascorbic acid
(50 µg/mL) (Sigma, St Louis, MO), insulin (0.5 µg/mL) (Sigma, St
Louis, MO). The culture medium was supplemented with epidermal
growth factor (EGF) (10 ng/mL) (BDBiosciences, San Jose,CA,USA)
at the time of air exposure. The culturemediawere renewed every two
days. Air-lifted cultures were harvested, embedded in OCT, and cryo-
sectionswere stainedwithH&E for analysis. In someexperiments, the
dermal ﬁbroblasts were infected with premade adenovirus SDF-1
(Vigene Biosciences, Rockville, MD, USA) before being embedded in
collagen lattices.
[3H]Thymidine incorporation assay
[3H]Thymidine incorporation was assayed as follows. Skin equiva-
lent cultures were prepared as described above, and 1 μCi/well [3H]
methylthymidine (Amersham Pharmacia Biotech, Pittsburgh, PA,
USA) was added, and incubation was continued for an additional
16 h. The cells were harvested, and washed three times with ice-
cold phosphate-buffered saline, incubated in 10% trichloroacetic
acid for 1 h, and incubated with a solution consisting of 0.3 mol/L
NaOH and 1% SDS for 2 h. The cells were lysed by vortexing and
their radioactivity, which reﬂects the [3H]thymidine incorporation and
DNA synthesis, was determined by liquid scintillation counting.
Statistical analysis
Data are expressed as mean ± SEM. Student’s t-test was used to
evaluate the statistical differences among the groups. All P values
are two-tailed, and values less than 0.05 were considered statisti-
cally signiﬁcant.
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